I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 7 studies | 45% ± 16% | |
| progenitor cell | 6 studies | 34% ± 17% | |
| transit amplifying cell | 6 studies | 36% ± 19% | |
| ciliated cell | 6 studies | 36% ± 8% | |
| plasmablast | 5 studies | 37% ± 6% | |
| epithelial cell of proximal tubule | 5 studies | 22% ± 3% | |
| macrophage | 5 studies | 23% ± 8% | |
| endothelial cell | 5 studies | 28% ± 11% | |
| goblet cell | 5 studies | 29% ± 9% | |
| intestinal crypt stem cell | 5 studies | 31% ± 12% | |
| basal cell | 5 studies | 35% ± 18% | |
| conventional dendritic cell | 4 studies | 29% ± 14% | |
| enterocyte | 4 studies | 22% ± 2% | |
| erythroblast | 4 studies | 38% ± 12% | |
| abnormal cell | 4 studies | 22% ± 6% | |
| natural killer cell | 4 studies | 17% ± 1% | |
| hematopoietic precursor cell | 3 studies | 36% ± 14% | |
| kidney loop of Henle epithelial cell | 3 studies | 22% ± 4% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 24% ± 1% | |
| enteroendocrine cell | 3 studies | 30% ± 6% | |
| pericyte | 3 studies | 23% ± 6% | |
| common myeloid progenitor | 3 studies | 21% ± 4% | |
| fibroblast | 3 studies | 27% ± 11% | |
| dendritic cell | 3 studies | 31% ± 9% | |
| granulocyte monocyte progenitor cell | 3 studies | 34% ± 14% |
